Platform
Company
Immunology & Autoimmune
Review status
Currently under review
Pending specialist review and validation.
This test measures C18OH, also called 3-hydroxyoctadecanoylcarnitine, a long-chain hydroxyacylcarnitine in your blood. It is formed when your body processes certain long-chain fats inside the mitochondria, the parts of cells that make energy. The measurement is usually part of an acylcarnitine profile used to evaluate how well fat is being broken down for energy.
Because hydroxyacylcarnitines reflect steps in mitochondrial beta-oxidation, this marker can help identify patterns linked to specific enzyme problems, including long-chain 3-hydroxyacyl-CoA dehydrogenase or related protein complexes. It is often used in newborns, children, and adults when doctors are assessing possible inherited metabolic disorders or unexplained metabolic symptoms.
Abnormal levels can signal fatty acid oxidation disorders that may lead to low blood sugar, muscle weakness, heart rhythm issues, liver stress, or episodes of lethargy during illness or fasting. Finding these problems early supports timely treatment, tailored nutrition, and prevention of complications.
Your clinician may order this test to follow up an abnormal newborn screen, investigate symptoms triggered by fasting, infection, or exercise, or monitor a known metabolic condition. Results are interpreted alongside other acylcarnitines, organic acids, clinical history, and sometimes genetic testing to narrow the diagnosis and guide care.
Your result is interpreted in the context of your age, health status, and other laboratory markers. A value that is higher than expected may suggest reduced capacity to process long-chain fats or a period of metabolic stress, but on its own it does not confirm a specific disorder. Lower or undetectable amounts can be normal and are assessed with other parts of the acylcarnitine profile.
If your result is unexpected, your clinician may repeat testing under stable conditions, review diet and medications, and consider additional tests such as a full acylcarnitine panel, plasma free carnitine, urine organic acids, or genetic studies. Avoid making major diet or supplement changes without guidance, especially for infants and children.
Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.
Fever, prolonged fasting, hard exercise, or other illness can increase fat breakdown and temporarily raise hydroxyacylcarnitines, which may influence the result.
Whether the sample is collected fasting or after a meal, and how quickly it is processed and stored, can affect acylcarnitine stability and measured levels.
Carnitine supplements, ketogenic or very high-fat diets, medium-chain triglyceride products, and some anticonvulsants can shift acylcarnitine patterns and complicate interpretation.
Newborns, especially premature infants, can have distinct metabolic patterns as they transition after birth, so age-specific interpretation is important.
Conditions that strain the liver, heart, or skeletal muscle may alter fatty acid oxidation and change hydroxyacylcarnitine levels independent of inherited disorders.
High-fat intake, low-carbohydrate plans, or prolonged intervals between meals can modify fat utilization and may influence results.
References